TIVC
Tivic Health Systems, Inc.NASDAQHealthcare$1.00-2.98%ClosedMarket Cap: $1.1M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.02
P/S
2.75
EV/EBITDA
0.65
DCF Value
$-4.98
FCF Yield
-91.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
8.4%
Operating Margin
-2067.5%
Net Margin
-2324.1%
ROE
-122.0%
ROA
-28.1%
ROIC
-25.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $-302.0K | -24.2% | $-2.0M | $6.0M | $6.68 | — |
| FY 2025 | $382.0K | 8.4% | $-7.9M | $-8.9M | $0.00 | — |
| Q3 2025 | $146.0K | -99.3% | $-2.5M | $-2.6M | $-1.97 | — |
| Q2 2025 | $86.0K | 62.8% | $-1.9M | $-1.9M | $-2.19 | — |
| Q1 2025 | $70.0K | 71.4% | $-1.5M | $-1.5M | $-2.52 | — |
| Q4 2024 | $180.0K | -132.8% | $-1.5M | $-1.5M | $-3.20 | — |
| FY 2024 | $780.0K | 0.3% | $-5.7M | $-5.7M | $-19.67 | — |
| Q3 2024 | $126.0K | 34.9% | $-1.4M | $-1.4M | $-3.93 | — |
| Q2 2024 | $140.0K | 21.4% | $-1.2M | $-1.3M | $-5.37 | — |
| Q1 2024 | $334.0K | 50.0% | $-1.5M | $-1.5M | $-17.15 | — |
| Q4 2023 | $357.0K | 0.8% | $-2.2M | $-2.2M | $-25.88 | — |
| FY 2023 | $1.2M | 24.4% | $-8.2M | $-8.2M | $-176.72 | — |